Compound Evidence File
#EC-2026-0872
Vilon
Filed under Peptides. The bureau holds 209 laboratory returns for this compound from 88 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
88 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Feb 2026 | 25 Apr 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 10.0 | 10.0 | 20 Apr 2026 | 2 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 10.0 | 10.0 | 17 Dec 2025 | 7 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Jan 2026 | 4 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 27 Nov 2025 | 14 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 10 May 2026 | 17 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 10.0 | 10.0 | 18 Feb 2026 | 22 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 10.0 | 10.0 | 9 Jun 2026 | 4 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 2 Apr 2026 | 15 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 10.0 | 10.0 | 9 Jun 2026 | 10 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 26 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 10.0 | 10.0 | 15 Dec 2025 | 6 Aug 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Mar 2026 | 17 Apr 2026 |
| TCICASE #VI-2026-0650 | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 | 27 Feb 2025 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Mar 2026 | 1 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Jan 2026 | 16 Apr 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 25 Apr 2026 | 1 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 4 May 2026 | 1 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 21 Mar 2026 | 11 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 21 Feb 2026 | 20 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 18 Mar 2026 | 28 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 9.9 | 10 Jan 2026 | 19 Jun 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | X | 1 | 9.7 | 9.7 | 9.7 | 28 Mar 2025 | 28 Mar 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 9.3 | 9.3 | 9.3 | 17 Dec 2024 | 17 Dec 2024 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 9.1 | 7.4 | 10.0 | 25 May 2026 | 25 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.9 | 8.2 | 9.7 | 23 May 2026 | 23 May 2026 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 1 | 8.8 | 8.8 | 8.8 | 28 Mar 2025 | 28 Mar 2025 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 8.8 | 8.8 | 8.8 | 20 Jun 2025 | 20 Jun 2025 |
| Astro PeptidesCASE #VI-2026-0424 | X | 1 | 8.6 | 8.6 | 8.6 | 20 Jun 2025 | 20 Jun 2025 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 8.6 | 8.6 | 8.6 | 21 May 2025 | 21 May 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.4 | 6.6 | 10.0 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.3 | 6.9 | 9.3 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.2 | 6.9 | 9.8 | 24 May 2026 | 24 May 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 8.2 | 8.2 | 8.2 | 25 Apr 2025 | 25 Apr 2025 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 8.2 | 8.2 | 8.2 | 13 Feb 2025 | 13 Feb 2025 |
| CellupepCASE #VI-2026-0888 | X | 1 | 8.1 | 8.1 | 8.1 | 16 Mar 2025 | 16 Mar 2025 |
| ScienceCASE #VI-2026-0636 | X | 1 | 8.0 | 8.0 | 8.0 | 16 Mar 2025 | 16 Mar 2025 |
| ZhuoYan labCASE #VI-2026-0902 | X | 3 | 7.9 | 6.9 | 9.5 | 21 May 2025 | 19 Jan 2026 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 7.9 | 7.9 | 7.9 | 13 Jun 2025 | 13 Jun 2025 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 7.5 | 7.5 | 7.5 | 11 Jun 2025 | 11 Jun 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 7.4 | 7.4 | 7.4 | 24 Apr 2025 | 24 Apr 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 7.3 | 7.3 | 7.3 | 24 Apr 2025 | 24 Apr 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 7.3 | 7.3 | 7.3 | 9 Jun 2025 | 9 Jun 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 1 | 7.3 | 7.3 | 7.3 | 13 Feb 2025 | 13 Feb 2025 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 7.3 | 7.3 | 7.3 | 20 Jun 2025 | 20 Jun 2025 |
| Zztai PeptideCASE #VI-2026-0192 | X | 1 | 7.2 | 7.2 | 7.2 | 11 Jun 2025 | 11 Jun 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 7.2 | 7.2 | 7.2 | 11 Jun 2025 | 11 Jun 2025 |
| OupeptideCASE #VI-2026-0435 | X | 8 | 7.1 | 5.8 | 9.3 | 3 Jul 2025 | 21 May 2026 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 2 | 7.0 | 6.4 | 7.5 | 17 Dec 2024 | 21 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 7.0 | 7.0 | 7.0 | 17 Dec 2024 | 17 Dec 2024 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 1 | 6.9 | 6.9 | 6.9 | 14 Jan 2025 | 14 Jan 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 6.9 | 6.9 | 6.9 | 13 Jun 2025 | 13 Jun 2025 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 3 | 6.8 | 6.4 | 7.5 | 11 Jun 2025 | 21 May 2026 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 6.8 | 6.8 | 6.8 | 27 Feb 2025 | 27 Feb 2025 |
| ZZQ PeptidesCASE #VI-2026-0550 | E | 2 | 6.7 | 5.5 | 7.8 | 14 Jan 2025 | 20 May 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 6.7 | 6.7 | 6.7 | 17 Dec 2024 | 17 Dec 2024 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 6.7 | 6.7 | 6.7 | 21 May 2025 | 21 May 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 3 | 6.6 | 6.0 | 7.6 | 3 Jul 2025 | 24 May 2026 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 8 | 6.5 | 5.2 | 8.3 | 8 Jul 2025 | 20 May 2026 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 6.5 | 6.5 | 6.5 | 3 Jun 2025 | 3 Jun 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 6.5 | 6.5 | 6.5 | 24 Apr 2025 | 24 Apr 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 1 | 6.4 | 6.4 | 6.4 | 8 Jul 2025 | 8 Jul 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 6.3 | 5.7 | 6.9 | 14 Jan 2025 | 26 Jan 2026 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 8 | 6.1 | 3.9 | 8.2 | 21 May 2025 | 20 May 2026 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 3 | 6.0 | 5.0 | 7.1 | 13 Feb 2025 | 25 May 2026 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 5.9 | 5.9 | 5.9 | 2 Jul 2025 | 2 Jul 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 5.8 | 5.8 | 5.8 | 2 Jul 2025 | 2 Jul 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 5.7 | 5.7 | 5.7 | 13 Jun 2025 | 13 Jun 2025 |
| HXNetCASE #VI-2026-0061 | X | 8 | 5.5 | 4.7 | 6.8 | 8 Jul 2025 | 24 May 2026 |
| PeptiSlimCASE #VI-2026-0557 | X | 1 | 5.5 | 5.5 | 5.5 | 2 Jul 2025 | 2 Jul 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 5.5 | 5.5 | 5.5 | 14 Jan 2025 | 14 Jan 2025 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 5.4 | 5.4 | 5.4 | 14 Jan 2025 | 14 Jan 2025 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 | 24 Apr 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 5.1 | 5.1 | 5.1 | 21 May 2025 | 21 May 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 5.0 | 5.0 | 5.0 | 2 Jul 2025 | 2 Jul 2025 |
| Platinum CryoCASE #VI-2026-0406 | X | 2 | 4.9 | 4.6 | 5.3 | 3 Jul 2025 | 24 May 2026 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 4.3 | 4.3 | 4.3 | 7 May 2025 | 7 May 2025 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 4.2 | 4.2 | 4.2 | 9 Jun 2025 | 9 Jun 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 4.2 | 4.2 | 4.2 | 16 Mar 2025 | 16 Mar 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 4.2 | 4.2 | 4.2 | 2 Apr 2025 | 2 Apr 2025 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 4.0 | 4.0 | 4.0 | 6 May 2025 | 6 May 2025 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 4.0 | 4.0 | 4.0 | 13 Jun 2025 | 13 Jun 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 3.5 | 3.5 | 3.5 | 7 May 2025 | 7 May 2025 |
| PepLab SolutionsCASE #VI-2026-0431 | X | 1 | 0.2 | 0.2 | 0.2 | 21 May 2025 | 21 May 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 27 Feb 2025 | 27 Feb 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.0 | 0.0 | 0.0 | 11 Jun 2025 | 11 Jun 2025 |
Open any subject to view the batch-level evidence for Vilon alone.